IndraLab

Statements

OTUD6B inhibits Carcinoma, Renal Cell. 2 / 2

| 2

reach

"It has reported that OTUD6B downregulated in kidney clear cell renal cell carcinoma, kidney renal papillary cell carcinoma compared to healthy sample (Zhao G. et al., 2022), (Guo et al., 2022), and its expression level correlated with survival in VHL missense mutation patients."

40034749

➶

reach

"The deubiquitinase OTUD6B inhibits cell migration in clear cell renal cell carcinoma and hepatocellular carcinoma by stabilizing mutated pVHL [16]."

38880876

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

OTUD6B inhibits Carcinoma, Renal Cell. 2 / 2

INDRA sources:

Databases

Reading